Canaland

Contact our Innovation Team

Next steps

We would like to hear from interested parties that already hold the relevant IP, or are close to patenting a particular technology or even just have an idea at this stage and require informal guidance.

This should be done by writing a brief (one side of A4 maximum) synopsis of the technology, stating why it would benefit the pharmaceutical industry or patients. It would be useful for the author to highlight the key benefits of this new technology and why it is innovative.

This disclosure can be confidential, and if required, a confidentiality agreement can be established should it be necessary for any discussions.

To submit your synopsis, or ask any questions, please contact:

innovation@canalandpharm.com